Related Experiment Videos
Cytotoxic therapy of gastroenteropancreatic (GEP) tumors
K N Syrigos1, D Sitara, E Georgiou
13rd Department of Medicine, Sotiria General Hospital, Athens Medical School, Greece. knsyrigos@usa.net
Abstract:
Neuroendocrine gut and pancreatic tumors have provided a diagnostic and therapeutic challenge over the years. Although they are considered slow growing, when disseminated their prognosis is poor. Currently, the various therapeutic options available for patients with inoperable GEP tumors aim either to control symptoms engendered by bioactive mediators, released by tumor cells, or to achieve control of tumor proliferation. The interpretation of the efficacy of the cytotoxic therapy on GEP tumors is hampered by the small size of the studies performed and the inconsistence in tumor type, origin and degree of differentiation. Nevertheless, it is widely recognized that chemotherapy has some role in the management of Neuroendocrine Pancreatic Tumors (NPTs); while in Metastatic Carcinoid Tumors (MCTs) it has only a minimal effect.
Insights
Chemotherapy offers some benefit for neuroendocrine pancreatic tumors (NPTs), but has minimal effect on metastatic carcinoid tumors (MCTs). Challenges in interpreting treatment efficacy persist due to study limitations.
Area of Science:
- Oncology
- Gastroenterology
- Endocrinology
Background:
- Neuroendocrine gut and pancreatic tumors (GEP) present diagnostic and therapeutic challenges.
- Disseminated GEP tumors have a poor prognosis despite slow growth.
- Current therapies focus on symptom control and tumor proliferation management.
Purpose of the Study:
- To evaluate the role of chemotherapy in managing GEP tumors.
- To clarify the efficacy of cytotoxic therapy in Neuroendocrine Pancreatic Tumors (NPTs) and Metastatic Carcinoid Tumors (MCTs).
Main Methods:
- Review of existing studies on chemotherapy for GEP tumors.
- Analysis of treatment outcomes based on tumor type, origin, and differentiation.
Main Results:
- Chemotherapy shows a recognized role in managing NPTs.
- Chemotherapy has a minimal effect on MCTs.
- Interpretation of cytotoxic therapy efficacy is limited by small study sizes and inconsistencies.
Conclusions:
- Chemotherapy is a component of NPT management.
- MCTs show limited response to chemotherapy.
- Further research with consistent methodologies is needed to accurately assess GEP tumor treatment efficacy.